The prognosis of follicular lymphomas: the F2-project

Published: June 8, 2009
Abstract Views: 171
PDF: 247
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Follicular lymphoma (FL) accounts for 10–15% of non-Hodgkin’s lymphomas in western countries. Although patients with FL experience a relatively indolent course and usually exhibit dramatic responses to initial therapy, they should be considered affected by a fatal malignancy. There is a tendency to relapse over time, the response to salvage treatments is of shorter duration after every relapse, and patients eventually die of disease-related causes. Several treatment approaches are offered to patients with FL; however, criteria to rationalize treatment decisions are still lacking in many instances.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Federico, M., & Bellei, M. (2009). The prognosis of follicular lymphomas: the F2-project. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.410